The U.S. DEA reaffirmed its stance against medical marijuana yesterday, restating that the drug should remain a Schedule I substance. The decision keeps the federal government at odds with 25 states and the District of Columbia (including Louisiana), which have passed laws allowing medical use of marijuana to varying degrees. Members of Congress have called for its reclassification and on Wednesday, the National Conference of State Legislatures adopted a resolution asking the federal government to remove marijuana from Schedule I. The DEA’s stance also keeps insurers in the workers’ comp and general health spaces in limbo; some states like New Mexico require reimbursement for a claimant’s medical marijuana but its illegality under federal law creates additional risk.
Read more from the Washington Post here.